Redefining Syringes: A 71% Carbon Footprint Reduction with RAUMEDIC’s Green Syringe
RAUMEDIC’s Green Syringe sets a new standard in sustainable drug delivery devices, reducing the product carbon footprint by 71%. With renewable biopolymers, optimized logistics, and recycling concepts, it ensures eco-friendly solutions without compromising functionality.
71% Less Carbon Emissions:
A Sustainable Step Forward in Pharma Packaging
RAUMEDIC’s Green Syringe isn’t just a product—it’s a prototype demonstrating the seamless transition from fossil-based materials to renewable options. The Green Syringe’s value proposition is simple: in its scope of influence, RAUMEDIC can reduce CO2 emissions by 71% - compared to the chemically equivalent “traditional” polymeric syringe.
“With a housing and rod made from polypropylene (PP), retaining the same chemical properties as its fossil-based counterpart, the Green Syringe offers a sustainable design. The stopper is made from biopolymeric thermoplastic elastomers (TPE) instead of silicone, enhancing the ecological footprint of the stopper.”
This is backed by a declaration of equivalency of RAUMEDIC’s material supplier, ensuring that the materials used in the Green Syringe meet all necessary regulatory requirements and standards, just like their fossil predecessors.
This means that even with the switch to more sustainable, ISCC PLUS renewable materials, can ensure regulatory compliance without the need for additional approvals or changes to the production process. This makes it easier for customers to adopt environmentally friendly solutions without worrying about compliance issues.
- Material footprint: A 44% reduction due to the use of sustainable, certified biopolymers – including ISCC PLUS materials.
- Logistics optimization: By shifting transportation from road to rail, emissions are reduced by 20.5%.
- Energy savings: On-site renewable energy generation at RAUMEDIC’s global headquarters accounts for a 6.5% reduction in emissions.
